Investors' heads have been turned by critical minerals, but there could be value on offer in unloved commodities like coal ...

The US Government push to build US$80bn worth of new nuclear reactors and VanEck’s launch of a uranium ETF are signs that ...

ReNerve (ASX:RNV) is a cutting-edge biotech developing “ready-to-use” products for nerve repair and regeneration.

Defence is having its biggest year in decades, and ASX defence stocks, from drones to secure-comms innovators, are suddenly ...

Hole AKDD210 has confirmed there’s more deep silver to find at Argent Minerals’ (ASX:ARD) Kempfield polymetallic project in ...

With the shutdown finally over, markets now turn to a backlog of missing labour and inflation data that could give investors ...

The ASX 200 plunged sharply in the first hour of trade, losing more than 100 points as 167 of 200 companies gave up ground.

Spodumene prices have passed US$1000/t thanks to booming demand from battery energy storage systems, and lithium miners are ...

Justin speaks with Nicky Agahari, founder and CEO of Australis Scientific, one of Australia’s most exciting emerging med-tech ...

The ASX fell heavily at lunch as hot jobs data crushed rate-cut hopes, gold took off, and DroneShield collapsed on insider ...

Havilah Resources has found a partner in Sandfire Resources to take forward its Kalkaroo copper and gold project in South ...

Ahead of EBR's official October 1 Us launch of its Wise device, surgeons have already used the heart tool in 12 procedures.